Stock Updates

Today’s Top Gainers in the Market Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) from Healthcare

Today’s top gainers include the company Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) which is in the industry Biotechnology, gaining 2.31% today. In the last week its performance is 4.08%, and 8.17% for the past quarter. Currently, Vertex Pharmaceuticals Incorporated, VRTX has a target price of 109.16, so today’s gain of 2.31% is a significant step towards its target price. The GAP today is therefore -0.40%.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), has a market cap of 23055.63, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 97.00%.

At the current price of 96.06, it has a dividend yield of *TBA, and its target price is 109.16. This is with a profit margin of -30.90%, and total debt/equity of 0.86. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has a P/E of *TBA, as well as a forward P/E of 29.79.

With a current EPS of -1.65, and a forecasted EPS growth for next year at 207.81%,Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has had a EPS growth for the past five years at 9.30%. For the next five years EPS growth is projected to be 51.20%.

Performance for the year is -28.25%. Since its IPO date on 7/24/1991, the total performance to date is -25.38%.

Volume today for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), is 864650, while its average volume is 1664.93. Whilst the total gain today was 2.31%, it did have a day high of -0.45%.

Volatility for this week has been at 3.04%, and 3.09% for the month. The 52-week low for Vertex Pharmaceuticals Incorporated, VRTX has been 26.56%, while the 52-week-high has reached -33.04%.

Looking at its return of investments, which is -28.20%, and its return on assets is -16.30%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has an operating margin of -23.90%. With a sales growth of 187.40% quarter over quarter. Bearing in mind that Vertex Pharmaceuticals Incorporated, VRTX is in the sector Healthcare, its long-term debt/equity is 0.69, and has a current ratio of 2.5 and 2.4 for quick ratio.

So what is the value of Vertex Pharmaceuticals Incorporated? Well its PEG is *TBA, and the P/S is 17.85, along with a P/B of 23.89. Meanwhile it has a p/cash of 22.48.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment